The global infection surveillance solutions market is projected to reach USD 508.8 Million by 2021, at a CAGR of 14.1% from 2016 to 2021. The market has witnessed substantial growth in the past few years driven by the increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditure, and increasing number of surgeries. However, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of the infection surveillance solutions market to a certain extent.

Geographically, the infection surveillance solutions market in North America and Europe accounted for large market shares owing to the increasing incidence of HAIs, government policies for preventing HAIs, rising healthcare expenditure in these regions. The Asia-Pacific region, especially Japan, China, and India, is expected to register highest growth owing to the rising incidences of HAIs, increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, and rapid improvement in the health insurance sector in these countries.

In order to maintain their market shares, major players focus on new product launches, product enhancements expansions, partnerships, agreements, and collaborations and acquisitions as key growth strategies. Of all these strategies, partnerships, agreements, and collaborations were the key strategies adopted by the major market players in the period of 2012 to 2016.

On the basis of product, the infection surveillance solutions market is segmented into software and services. The software segment held the largest share of the market in 2015, primarily due to higher adoption of infection surveillance software by healthcare facilities. Hospitals are the largest end users of infection surveillance solutions, followed by long-term care facilities.

Some of the prominent players in the global infection surveillance solutions market are Becton, Dickinson and Company (U.S.), Premier Inc. (U.S.), Wolters Kluwer N.V. (Netherlands,), Baxter International Inc. (U.S.), GOJO Industries, Inc. (U.S.), Atlas Medical Software (U.S.), Deb Group Ltd (U.K.), Hygreen Inc. (U.S.), RL Solutions (Canada), and TRUVEN Health Analytics (U.S.).

Target Audience

Infection surveillance software providers

Infection control practitioner

Hospitals and LTC facilities

Various research and consulting firms

Distributors of infection surveillance software

Healthcare institutions

Research institutes

Venture capitalists and investors

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

Infection surveillance is the ongoing systematic collection, analysis, and interpretation of healthcare-associated infections (HAIs) data essential for planning, implementation, and evaluation of public health practices, especially to curtail the rapid increase of nosocomial infections, such as central line-associated bloodstream infection (CLABSI), surgical site infection (SSI), ventilator-associated pneumonia (VAP), and catheter-associated urinary tract infection (CAUTI) in healthcare facilities.

Infection Surveillance Solutions Market

This research report categorizes the infection surveillance solutions market into the following segments:

Global Infection Surveillance Solutions Market, by Product Software On-premise Web-based Services Product Support & Maintenance Services Training & Consulting Services Implementation Services

Global Infection Surveillance Solutions Market, by End User Hospitals Large Hospitals Medium-sized Hospitals Small Hospitals Long-term Care Facilities Homecare Agencies & Hospices Nursing Homes Assisted Living Facilities Other End Users (primarily includes ambulatory care centers and academic institutes)

Global Infection Surveillance Solutions Market, by Region North America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe (RoE) Asia-Pacific (APAC) China Japan India Rest of APAC Rest of the World (RoW) Latin America Middle East & Africa



Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of the Rest of Asia-Pacific infection surveillance solutions market into South Korea, Australia, New Zealand, and others

Further breakdown of the Latin American infection surveillance solutions market into Brazil, Argentina, and the Rest of Latin America

The global infection surveillance solutions market is estimated to reach USD 508.8 Million by 2021, at a CAGR of 14.1% during the forecast period. The market is primarily driven by the increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditures, and increasing number of surgeries. On the other hand, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are some factors that are expected to limit the growth of the market in the coming years.

The global infection surveillance solutions market is segmented on the basis of product, end user, and region.

On the basis of products, the market is classified into software and services. The software segment is further segmented into on-premise and web-based software. The services included in this report are subdivided into product support & maintenance, training & consulting, and implementation services. By end user, the market is segmented into hospitals and long-term care facilities. Hospitals are further sub-divided on the basis of bed size into large, medium-sized, and small hospitals. Long-term care facilities included in this report are nursing homes, skilled nursing facilities, and assisted living facilities.

The global infection surveillance solutions market is further divided into four major regions North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. North America accounted for the largest regional market in 2015, followed by Europe. North America and Europe are expected to witness a healthy growth rate in the coming years, owing to the increasing incidence of HAIs, government policies for preventing HAIs, and rising healthcare expenditures.

The Asia-Pacific region, on the other hand, represents the fastest-growing market for infection surveillance solutions. The high growth rate in infection surveillance solutions market is primarily attributed to the rising incidences of HAIs, increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, and rapid improvements in the health insurance sector in the APAC countries.

This research report discusses the key market drivers, restraints, challenges, and opportunities in the global market and its submarkets. The leading players in the global Infection Surveillance Solutions Market include Becton, Dickinson and Company (U.S.), Premier Inc. (U.S.), Wolters Kluwer N.V. (Netherlands,), Baxter International Inc. (U.S.), and GOJO Industries, Inc. (U.S.). Other players in this market are Atlas Medical Software (U.S.), Deb Group Ltd (U.K.), Hygreen Inc. (U.S.), RL Solutions (Canada), and TRUVEN Health Analytics (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst